Home
»çÀÌÆ®¸Ê
Contact Us
Eng
¼¾ÅͼҰ³
¿¬±¸¿µ¿ª
¿¬±¸È°µ¿
¿¬±¸½ÇÀû
ÀÚ·á½Ç
°Ô½ÃÆÇ
×
¼¾ÅͼҰ³
Àλ縻
¼³¸³¸ñÀû
¿¬Çõ
Á¶Á÷µµ
Âü¿©¿¬±¸Áø
½Ã¼³ ¹× Àåºñ
¿À½Ã´Â ±æ
¿¬±¸¿µ¿ª
ÀÓ»ó¾à¹°À¯Àüü¿¬±¸ºÎ
ºÐÀھ๰À¯Àüü¿¬±¸ºÎ
¾à¹°À¯Àüü¿¬±¸ Áö¿øºÎ
¿¬±¸È°µ¿
¿¬±¸»ç¾÷
¿¬±¸°³¹ß
¿¬±¸Çù·ÂÁö¿ø
Àη¾缺
¿¬±¸½ÇÀû
ÁßÁ¡¿¬±¸ÀÚ·á
³í¹®½ÇÀû
ÇÐȸ¹ßÇ¥
ƯÇã½ÇÀû
±âŸ½ÇÀû
ÀÚ·á½Ç
º¸µµÀÚ·á
»çÁøÀÚ·á
°ü·Ã»çÀÌÆ®
°Ô½ÃÆÇ
Çà»çÀÏÁ¤
°øÁö»çÇ×
¼¾ÅͼҽÄ
Çаè¼Ò½Ä
Contact Us
Eng
³í¹®½ÇÀû
¿¬±¸½ÇÀû
ÁßÁ¡¿¬±¸ÀÚ·á
³í¹®½ÇÀû
ÇÐȸ¹ßÇ¥
ƯÇã½ÇÀû
±âŸ½ÇÀû
Áö¿ø°úÁ¦º° :
¼±ÅÃÇϱâ
BMRC
BMRC, Japan Fund
BMRC, PRCDM
BMRC, ¼ö¼Ûü
cPMTb
FRONTIER
FRONTIER, PRCDM
NRL
NRL, PRCDM
PRCDM
PRCDM, ¿¬±¸±³¼ö
RCTC
RCTC, BMRC
¿¬µµº° :
¼±ÅÃÇϱâ
2015-International
2015-Domestic
2014-International
2014-Domestic
2013-International
2013-Domestic
2012-International
2012-Domestic
2011-International
2011-Domestic
2010-International
2010-Domestic
2009-International
2009-Domestic
2008-International
2008-Domestic
2007-International
2007-Domestic
2006-International
2006-Domestic
2005-International
2005-Domestic
2004-International
2004-Domestic
2003-International
2003-Domestic
¸ðµÎº¸±â
·
Lee SJ, Kwon JA, Cho SA, Jarrar YB, Shin JG.
Effects of testosterone and 17¥â-oestradiol on expression of the G protein-coupled receptor P2Y12 in megakaryocytic DAMI cells.(BMRC, PRCDM)
Platelets. 23(8):579-85 / 2012.12 [
LINK
]
2012-International
·
Song IS, Lee do Y, Shin MH, Kim H, Ahn YG, Park I, Kim KH, Kind T, Shin JG, Fiehn O, Liu KH.
Pharmacogenetics meets metabolomics: discovery of tryptophan as a new endogenous OCT2 substrate related to metformin disposition.()
PLoS ONE. 7(5):e36637 / 2012.05 [
LINK
]
2012-International
·
Kim MH, Shin HJ, Lim SJ, Park JS, Lee SS, Song IS, Shin JG.
Inter-individual variability in OCT1 expression and its relationship with OCT1 genotype in liver samples from a Korean population.(BMRC, ¼ö¼Ûü)
Drug Metab Pharmacokinet. 27(5):530-5 / 2012.11 [
LINK
]
2012-International
·
Jo JC, Lee JL, Ryu MH, Chang HM, Kim M, Lee HJ, Kim HS, Shin JG, Kim TW, Kang YK
Phase II and UGT1A1 genotype study of irinotecan dose escalation as salvage therapy for advanced gastric cancer.(PRCDM)
Br J Cancer. 106(10):1591-7 / 2012.05 [
LINK
]
2012-International
·
Seo KA, Lee SJ, Kim KB, Bae SK, Liu KH, Kim DH, Shin JG.
Ilaprazole, a new proton pump inhibitor, is primarily metabolized to ilaprazole sulfone by CYP3A4 and 3A5.(BMRC)
Xenobiotica. 42(3):278-84 / 2012.03 [
LINK
]
2012-International
·
Horne BD, Lenzini PA, Wadelius M, Jorgensen AL, Kimmel SE, Ridker PM, Eriksson N, Anderson JL, Pirmohamed M, Limdi NA, Pendleton RC, McMillin GA, Burmester JK, Kurnik D, Stein CM, Caldwell MD, Eby CS, Rane A, Lindh JD, Shin JG, Kim HS, Angchaisuksiri P, G
Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy.(BMRC)
Thromb Haemost. 107(2):232-40 / 2012.02 [
LINK
]
2012-International
·
Shon JH, Ku HY, Bae SY, Oh MK, Yeo CW, Bae SK, Shin JG.
The disposition of three phosphodiesterase type 5 inhibitors, vardenafil, sildenafil, and udenafil, is differently influenced by the CYP3A5 genotype.(BMRC)
Pharmacogenet Genomics. 21(12):820-8 / 2011.12 [
LINK
]
2011-International
·
Kim KB, Seo KA, Kim SE, Bae SK, Kim DH, Shin JG.
Simple and accurate quantitative analysis of ten antiepileptic drugs in human plasma by liquid chromatography/tandem mass spectrometry.(BMRC)
J Pharm Biomed Anal. 56(4):771-7 / 2011.12 [
LINK
]
2011-International
·
Park HS, Choi JY, Lee MJ, Park S, Yeo CW, Lee SS, Shin JG, Park BW.
Association between Genetic Polymorphisms of CYP2D6 and Outcomes in Breast Cancer Patients with Tamoxifen Treatment.(BMRC)
J Korean Med Sci. 26(8):1007-13 / 2011.08 [
LINK
]
2011-International
·
Yoo HH, Kim NS, Kim MJ, Shin D, Shin JG, Kim DH.
Enantioselective carbonyl reduction of eperisone in human liver microsomes.(BMRC)
Xenobiotica. 41(9):758-63 / 2011.09 [
LINK
]
2011-International
[prev]
11
12
13
14
15
16
17
18
19
20
[Next]
Á¦¸ñ
ÀúÀÚ¸í
Áö¿ø°úÁ¦